ABSTRACT: PCDH19 is considered one of the most clinically relevant genes in epilepsy, second only to SCN1A. To date about 150 mutations have been identified as causative for PCDH19-female epilepsy (also known as early infantile epileptic encephalopathy-9, EIEE9), which is characterized by early onset epilepsy, intellectual disabilities, and behavioral disturbances. Although little is known about the physiological role of PCDH19 and the pathogenic mechanisms that lead to EIEE9, in this review, we will present latest researches focused on these aspects, underlining protein expression, its known functions and the mechanisms by which the protein acts, with particular interest in PCDH19 extracellular and intracellular roles in neurons.
INTRODUCTION
The cadherin superfamily contains a large number of cell adhesion molecules, which are transmembrane proteins whose extracellular domains mediate calcium-dependent intercellular interactions. These molecules can be classified into three main subfamilies: the classical cadherins, the protocadherins, and the desmosomal cadherins (Hulpiau and van Roy, 2009) .
Protocadherins represent the widest subgroup within the cadherin superfamily. This group comprises almost 80 members of (mostly) type I integral membrane proteins. Protocadherins are involved in signal transduction at synapses and in the establishment of neuronal connections (Zipursky and Sanes, 2010) . Based on structural differences among the different protocadherin genes, the members of the family are classified into different groups: α-, β-, and ƴ-protocadherins, which are clustered in a small genomic region; Flamingo/CELRS protocadherins, that possess a unique seven-pass transmembrane domain; fat-like protocadherins, that contain more than seven extracellular cadherin (EC) repeats; the novel subgroup of non-clustered protocadherins and other protocadherins that have different origins but still share similar structural domains with the other cadherins (Dibbens et al., 2008; Hulpiau and van Roy, 2009; Kim et al., 2011) .
The non-clustered protocadherins are predominately expressed in the central nervous system (CNS), where they contribute to neuronal development and CNS function, in particular neuronal migration, Developmental Neurobiology segregation, and synaptic plasticity (Kim et al., 2011) . These protocadherins are further divided into three subgroups: δ1-, δ2-, and ε-protocadherins.
Members of δ1 subgroup are protocadherin-1, -7, -9, and -11; these are the only protocadherins with seven EC repeats and three conserved motifs (CM1, CM2, and CM3). δ2-protocadherins comprise protocadherin-8, -10, -17, -18, and -19; they are composed by six EC repeats and have exclusively CM1 and CM2 in their cytoplasmic domain (Redies et al., 2005; Vanhalst et al., 2005; Wolverton and Lalande, 2001 ). ε-Protocadherins comprise protocadherin-15, -16, -21, and MUCDHL and, except for PCDH21, they have either higher or lower numbers of EC repeats than the other protocadherins. In particular, protocadherin-15, -16, and MUCDHL have 11, 27, and 4 EC repeats, respectively (Kim et al., 2011) .
In humans, mutations in the PCDH19 gene, that encodes protocadherin-19 (PCDH19) protein, cause early infantile epileptic encephalopathy-9 (EIEE9, OMIM # 300088), associated with intellectual disability and autistic features. EIEE9 affects heterozygous females and somatic mosaic males (Kolc et al., 2018) . Even though a complete picture of PCDH19 physiological role and EIEE9 pathogenic mechanisms is missing, recent studies provided the first insights into PCDH19 function.
In this review, we will summarize the current knowledge about the role of PCDH19 in neurons and in brain development.
PCDH19 STRUCTURE AND EXPRESSION PROFILES
PCDH19 gene is located on chromosome X (Xq22.1) and is composed by six exons. Exon 1 encodes the extracellular and transmembrane domains, as well as part of the intracellular tail, the rest of which is encoded by exons 2-6 (Dibbens et al., 2008; Redies et al., 2005) . PCDH19 ectodomain is composed by six conserved EC repeats (homologous of those of classical cadherins) that mediate calcium-dependent cellcell interactions (Dibbens et al., 2008; Redies et al., 2005) . The intracellular C terminal tail of PCDH19 contains the conserved motifs CM1 and CM2, and the Wiskott-Aldrich syndrome protein family verprolinhomologous protein (WAVE) regulatory complex (WRC) interacting receptor sequence (WIRS) Fig. 1) .
PCDH19 is expressed in various embryonic and adult tissues, including the kidney, lung, and trachea, but its prominent expression is in the nervous system (Gaitan and Bouchard, 2006; Wolverton and Lalande, 2001 ), especially in limbic areas (such as amygdala, hippocampus, and ventral hypothalamus) and cortex (Kim et al., 2007; Krishna et al., 2009; Pederick et al., 2016) .
In situ hybridization on the mouse embryo revealed a weak PCDH19 expression in the forebrain region from embryonic day (E) 9.0, which becomes prominent and extended to the midbrain and part of the hindbrain by E9.5 (Gaitan and Bouchard, 2006; Kim et al., 2010) .
While PCDH19 expression increases during brain development, a transient downregulation of PCDH19 transcripts has been observed in mouse cortex between E14.5 and E16.5. This has been attributed to the concomitant upregulation of miR-484, which is able to bind a specific target sequence in the 3′-untraslated region of PCDH19 mRNA and to inhibit PCDH19 mRNA stabilization and translation. As a consequence of PCDH19 downregulation, radial glia (RG) proliferation is decreased, while the differentiation of RG into basal progenitors is promoted (Fujitani et al., 2017) . Therefore, these results suggest a role of PCDH19 in the proliferation of neuronal progenitors (Fig. 1A) .
Furthermore, in the last embryonic period, PCDH19 expression increases and peaks in the first postnatal period in both rodent hippocampus and cortex. Despite lower expression levels in the adult rodent brain compared to the perinatal period (Bassani et al., 2018; Fujitani et al., 2017) , electroconvulsive shock brain stimulation was able to upregulate PCDH19 mRNA levels in the rat hippocampus (Kim et al., 2010) . Altogether these data suggest that the role of PCDH19 encompasses both the formation of neuronal circuits and the regulation of neuronal activity.
At the cellular level, PCDH19 expression has been reported in both glial cells (Zhang et al., 2014) and pyramidal neurons (Bassani et al., 2018; Hayashi et al., 2017) . In the cortex, PCDH19 is expressed in neurons of the layers IV and V (Krishna et al., 2009; Pederick et al., 2016) and in the hippocampus it is expressed in both cornus ammonis (CA) regions and dentate gyrus (DG). In particular, in the developing rat hippocampus, PCDH19 expression is the highest in CA1 and CA3 regions with respect to the DG, while it is the highest in the DG than other CA regions in adult brain (Gaitan and Bouchard, 2006; Hertel and Redies, 2011; Kim et al., 2007; Krishna-K et al., 2011) . In pyramidal neurons, PCDH19 has been detected along dendrites partially localizing with synapses (Bassani et al., 2018; Hayashi et al., 2017) , supporting PCDH19 role in neuronal connectivity. .1) is transcribed into an mRNA composed by six exons (E1-E6, canonical isoform), which is translated into protocadherin-19 protein (PCDH19). The 3′-untraslated region (3′-UTR) of PCDH19 mRNA contains a target-seed sequence for miRNA-484 that inhibits PCDH19 mRNA stabilization and translation. PCDH19 is composed by: an extracellular domain with six extracellular cadherin (EC1-EC6) repeats; a transmembrane region (TM); an intracellular C-terminus with two conserved regions (CM1 and CM2) and the WRC-interacting receptor sequence (WIRS) (SP, signal peptide). The EC and cytoplasmic domains mediate, respectively, cell-adhesion, through homophilic interactions and heterophilic interaction with N-cadherin (NCAD), and intracellular signaling and trafficking, through interaction with γ-aminobutyric acid, type A, receptors (GABA A Rs), non-POU domain-containing octamer binding protein (NONO), and the wave regulatory complex (WRC). (A) Regulation of PCDH19 mRNA levels through miRNA-484 action: miRNA-484, reducing PCDH19 expression, decreases radial glia (RG) proliferation and promotes RG differentiation into basal progenitors (BPs), thus regulating embryonic cortical neurogenesis. (B) PCDH19 interactions with PCDH19 in trans and with NCAD in cis provide a mechanism to regulate cell migration and neuronal circuit formation. (C) PCDH19 binds the alpha subunits of GABA A R and favors its surface expression, regulating GABAergic transmission. (D) Association of PCDH19 C-terminus to the fully assembled WRC through a binding surface formed by the Cyfip/Sra and Abi subunits: PCDH19 is able to enhance Rac1-mediated WRC activation, which regulates actin cytoskeleton dynamics via the Arp2/3 complex. (E) Representation of PCDH19-NONO-estrogen receptor (ER) α axis proposed to be involved in the ERα-dependent regulation of a subset of genes, including the steroidogenic enzyme AKR1C3. [Colour figure can be viewed at wileyonlinelibrary.com] Developmental Neurobiology
PCDH19 FUNCTIONS
Most of the disease-linked mutations occur in the extracellular domain of PCDH19 (Dibbens et al., 2008; Jamal et al., 2010; Kolc et al., 2018) highlighting its relevance in the pathogenesis of EIEE9. Therefore, a number of studies were focused on the adhesive properties of PCDH19 extracellular domain. However, recently, the biological roles of PCDH19 intracellular domain started emerging, thanks to the identification of intracellular partners suggesting PCDH19 involvement in different cell signaling pathways.
PCDH19 EXTRACELLULAR DOMAIN AND ITS ROLE IN CELL ADHESION
Cell-cell interactions play an important role in organized tissues such as the nervous system, whose function is highly dependent on correct circuit assembly. The precise and coordinated control of cellcell interactions at nearly all stages of development is fundamental for neuronal differentiation and migration, axon outgrowth, dendrite arborization, and synapse formation and maintenance (Weiner and Jontes, 2013) . Classical cadherins and protocadherins, whose expression is temporally and spatially regulated, play an important role in all these processes. Defects in the expression and/or function of these proteins correlate with several neurodevelopmental disorders, such as autism, intellectual disabilities, congenital microcephaly, and epilepsy. These evidences highlight their importance in controlling neuronal tissue architecture (Redies et al., 2012) .
It has been shown, In zebrafish (Danio rerio), that Pcdh19 is essential during the early stages of neurulation in embryos (Biswas et al., 2010; Emond et al., 2009) and in the formation of optical tectum (Cooper et al., 2015) . Indeed, thanks to its specific expression in discrete columns of neurons and its adhesive properties, Pcdh19 contributes to the maintenance of the optical tectum architecture. This evidence is supported by the observation that absence of Pcdh19 leads to the loss of cell-cell cohesion and to an aberrant cell proliferation rate (Cooper et al., 2015) .
While the mechanisms of homophilic calcium-dependent cell-cell interactions due to classical cadherins are fully understood (Perez and Nelson, 2004) , the mechanisms and role of the weaker homophilic interactions due to protocadherins, including PCDH19, is less clear and it has been proposed that some of them might play a more indirect role in adhesion rather than acting as bona fide cell adhesion molecules (Tai et al., 2010) .
Classical cadherin-mediated cell adhesion involves a tip-to-tip interaction of cadherin molecules that is further stabilized by the reciprocal exchange of tryptophan residues at the N-terminal of the EC1 repeat (Kim et al., 2011; Shapiro et al., 1995; Tamura et al., 1998) . Non-classical cadherins and protocadherins do not have this tryptophan residue, meaning that they interact through a different mechanism. Recently, the EC1-4 repeats of PCDH19 have been identified as the minimal adhesive unit involved in the generation of a trans adhesive interface. These repeats interact in an antiparallel PCDH19 dimer (forearm handshake model) (Fig. 1B) . This model can be broadly applied and might be relevant for all the other non-clustered delta protocadherins and clustered protocadherins (Cooper et al., 2016) .
Besides forming homodimers in trans, Pcdh19 associates with Ncad in cis and this interaction is mediated by their extracellular domains (Fig. 1B) . In particular, it has been demonstrated that the Pcdh19-Ncad complex is required for the early steps of brain morphogenesis in zebrafish and, given the weaker adhesive properties of Pcdh19 with respect to Ncad, it was hypothesized that Pcdh19 might serve as a cofactor for Ncad (Biswas et al., 2010; Emond et al., 2009 ). However, subsequent in vitro studies revealed that is Pcdh19 that confer robust adhesive properties to this complex, which indeed displays unique adhesive properties, distinct from those of the two single molecules (Emond et al., 2011) .
PCDH19 FUNCTIONS IN CELL SIGNALING
Cadherins and protocadherins functions are exerted not only through their adhesive properties, but also through the modulation of intracellular signaling pathways. In neurons, this modulation is fundamental to convey and integrate synaptic inputs and to build up adequate responses for neuronal development, plasticity, and survival.
WAVE Regulatory Complex
Among the interactors of protocadherins, enzymes and regulators of the cytoskeleton have been identified. In particular, the members of the δ1-protocadherin subgroup interact with protein phosphatase-1α (PP1α), whereas α-protocadherin members interact with the tyrosine kinase Fyn, and ƴ-protocadherin members with the microtubule-destabilizing protein SCG10 (Gayet et al., 2004; Kohmura et al., 1998) .
Developmental Neurobiology
Concerning PCDH19, it has been shown to interact with the WRC, which is involved in the regulation of actin cytoskeleton dynamics. PCDH19 C-terminus harbors a WIRS motif (amino acids: FATFGK), which associates to the fully assembled WRC includes WAVE, hematopoietic stem/progenitor cell protein 300 (HSPC300), cytoplasmic interactor of FMRP 1 and 2 (CYFIP1/2), Nck-associated protein (NAP1), and Abelson interactor 1 protein (Abi1). PCDH19 is thus able to enhance Rac1-mediated WRC activation, which regulates actin cytoskeleton dynamics via the actin related protein 2/3 (Arp2/3) complex (Fig. 1D) (Hayashi et al., 2017; Nakao et al., 2008; Tai et al., 2010) .
The finding that PCDH19 downregulation in rat hippocampal neurons affects the dendrite morphology, suggests a role of PCDH19 in cytoskeleton organization (Bassani et al., 2018) , that might be broader and extended to microtubule dynamic, as demonstrated for several protocadherins (Keeler et al., 2015) . In particular, it has been shown that the silencing of PCDH19 in mouse hippocampus during neuronal cells maturation and migration, leads not only to ectopic localization of some neurons, but it also decreases the total dendritic length and increases the average length of basal dendrites compared to that of apical dendrites ( Fig. 2 ; Bassani et al., 2018) . Neuronal migration and dendritic morphology are thus affected by PCDH19 loss of function; both events are fundamental for proper neuronal circuit formation and these observations confirm the relevance of PCDH19 during brain development. These data are paralleled by the observation that knockdown of Cyfip1 (one of the intracellular interactors of PCDH19, see above) in mouse cortical neurons similarly affects the complexity and the architecture of their dendritic arbors (Abekhoukh and Bardoni, 2014; Abekhoukh et al., 2017) . Further, it has been shown a direct correlation between mRNA levels of Cyfip1 and those of WRC members and the importance, for WRC stability, of the correct stoichiometric relationship between its components: altered expression of one of WRC components impairs proper cell functions, like neuronal development and circuit formation (Abekhoukh et al., 2017) . Indeed, also the knockdown of WAVE-1 causes a reduction of the extent of neurite outgrowth in mice hippocampal neurons and a reduction in spines density (Hazai et al., 2013; Soderling et al., 2007) .
Despite all these evidences, PCDH19 role in neuronal morphology still needs in-depth analysis and might be limited to some neuronal subtypes, since for instance, no morphological defects in dendrites and dendritic spines have been observed in neurons of the cortical layer V of Pcdh19 knock out mice (Hayashi et al., 2017) .
GABA A R Alpha Subunits
The most relevant phenotype that characterizes EIEE9 patients is the presence of seizures. Seizures are the consequence of lack of balance between excitatory and inhibitory transmission in neuronal circuits (Bradford, 1995; Gale, 1992; Olsen and Avoli, 1997) . GABA A receptor (GABA A R) mediates fast inhibitory neurotransmission in the brain (Fritschy, 2008) and recent studies unveiled the involvement of PCDH19 in GABA A R function. Indeed, it was demonstrated that PCDH19 cytoplasmic region binds the GABA A R alpha subunits and is able to regulate the receptor surface availability, suggesting that PCDH19 might be involved in the regulation of GABA A R intracellular trafficking (Bassani et al., 2018) (Fig. 1C) . In addition, hippocampal neurons in which PCDH19 has been downregulated display less frequency mIPSCs (miniature inhibitory post-synaptic currents) characterized by a slower decay kinetic. Noteworthy, the regulation of GABAergic signaling is important for adult brain inhibitory neurotransmission but also for brain development, given that migration and morphological maturation of neurons rely on the trophic excitatory action of GABA A Rs (Deidda et al., 2014) .
PCDH19-NONO-ERα Axis
GABAergic impairment, associated with PCDH19 altered expression, might not be due to the solely defects of the GABA A R itself, but also to its positive modulators, like the neurosteroid allopregnanolone. In fact, a reduced expression level of AKR1C3 has been found in fibroblasts from EIEE9 patients (Tan et al., 2015) . AKR1C3 is one of the key enzymes that metabolize steroid hormones into neurosteroids, in particular into allopregnanolone. Since EIEE9 patients present reduced blood levels of allopregnanolone (Tan et al., 2015) , this might lead to neuronal hyperexcitability and contribute to the epileptic phenotype (Lappalainen et al., 2017) .
Furthermore, a number of genes whose expression is under the control of estrogen, progesterone, and androgen receptors were also deregulated in patients fibroblasts (Tan et al., 2015) . The precise mechanism by which PCDH19 regulates the expression level of these genes and of allopregnanolone remains still unclear. It has been proposed that this regulation involves the interaction of PCDH19 with the non-POU domain-containing octamer binding protein p54nrb/ NONO, which is a multifunctional RNA-and DNAbinding protein playing different roles in gene expression regulation (Fig. 1E) . Loss of NONO function has been recently associated with intellectual disability in patients, as well as cognitive deficits and inhibitory synapses dysfunction in mice (Mircsof et al., 2015) . These data suggest that both PCDH19 and NONO, and their complex, are crucial for proper neuronal development. It is still unclear how and where this interaction occurs and how it can modulate gene expression via the estrogen receptor (ERα) activation, enhancing its transcriptional activity (Pham et al., 2017) . However, these findings highlight the importance of steroid/ hormone receptor signaling in neurodevelopmental disorders, suggesting new putative pathogenic mechanisms for EIEE9 pathology.
MUTATIONS IN PCDH19 GENE AND ENCEPHALOPATHIES
The correct function of a neuronal circuit not only depends on the intrinsic activity of each single neuron forming the network, but also fundamentally relies on external factors such as cell-cell adhesion molecules, which compose the extracellular milieu. According to the lock and key model (Sperry, 1963) , neurons belonging to a given circuit recognize each other through "chemoaffinity labels" as protocadherins. Altered function of non-clustered protocadherins (δ1, δ2, and ε) has been linked to neurodevelopmental disorders such as autism spectrum disorders, intellectual disability, congenital microcephaly, and epilepsy (Ishizuka et al., 2016; Morrow et al., 2008) .
PCDH19 gene is primarily expressed in the developing vertebrate nervous system. Its pattern of expression is consistent with a role of the protein in brain development and in the development of cognitive functions (Bassani et al., 2018; Dibbens et al., 2008; Wolverton and Lalande, 2001 ). PCDH19 protein is a member of the δ2-protocadherins subgroup and its functional roles in the human brain, despite recent studies in animal models, remain poorly understood.
Mutations in the PCDH19 gene, located on chromosome X, cause a female and mosaic-male limited form of infant-onset epilepsy that is associated with intellectual disability and autistic features (EIEE9). About 150 mutations in the PCDH19 gene have been identified up to date in EIEE9 patients. Among them, whole and partial gene deletions together with point mutations (missense, nonsense, or frameshift) were reported (Depienne and Leguern, 2012; Dibbens et al., 2008; Jamal et al., 2010; Kolc et al., 2018; Leonardi et al., 2014) . Roughly 50% of these are missense mutations occurring within the extracellular adhesive domain. These mutations might affect protein function by interfering with homophilic adhesion or preventing interactions in cis with other cadherins, such as NCAD. Alternatively, missense mutations might impair PCDH19 folding and stability, thus reducing its amount at the cell surface, or shifting the calcium affinity of PCDH19, thus again compromising its stability (Cooper et al., 2016) .
The peculiar inheritance pattern of EIEE9 and the precise mechanisms that contribute to epileptogenesis and intellectual disabilities are not well understood. One of the proposed molecular mechanisms that would lead to EIEE9 is the cellular interference model. According to this model, the simultaneous presence of PCDH19 positive and negative cells is pathogenic because of the scrambled cell-cell communication between the two different populations of cells. Following the cellular interference , PCDH19-mediated circuit formation and functioning would be compromised. This condition has been well described in PCDH19 null mice, in which it has been observed a mosaic pattern with segregation between wild-type and PCDH19 knock out neurons expressing βGal-cassette (Pederick et al., 2016) . Mutations affecting the structure, the expression or the adhesive properties of PCDH19 extracellular domain could be the cause of this defective intercellular communication.
Malformations of the cerebral cortex are an important cause of developmental disabilities and epilepsy. Initial studies on PCDH19 knock-out mice (Pederick et al., 2016) revealed no gross brain morphological defects, suggesting that PCDH19 was dispensable for brain development in species other than zebrafish. However, more recent studies reported the presence of cortical malformations in EIEE9 patients (Kurian et al., 2018; Pederick et al., 2018) reinforcing the idea of PCDH19 involvement in cellular processes that ultimately influence brain morphology, such as neuronal migration.
As mentioned above, perturbation of cell adhesion affinities, due to PCDH19 loss, affected zebrafish optical tectum architecture (Biswas et al., 2010; Cooper et al., 2015; Emond et al., 2009) . Furthermore, loss of PCDH19 results in migration impairment, increased neurogenesis and loss of polarity both in human neural stem cells and in cultured neurons derived from Pcdh19 null mice (Homan et al., 2018) . Other studies on Pcdh19 null mice show both increased and abnormal neuronal mobility, resulting in impairment in neuronal migration (Pederick et al., 2016) . In particular, Pederick and colleagues demonstrated that PCDH19 loss of function in cortical neural progenitor cells results in increased neuronal migration, observed in neurospheres derived from these progenitor cells.
During brain development, neuronal migration plays a crucial role in neuronal tissue organization, thus defects derived by PCDH19 loss of function could be one of the mechanism that lead to cortical malformations observed in some EIEE9 patients (Pederick et al., 2018) .
Given PCDH19 important roles in pathways related to cytoskeletal dynamics and GABAergic signaling, impairment also in its intracellular functions could concur to defects in cortical development (Bassani et al., 2018) .
Till today, only few mutations were identified in the intracellular segment of the protein possibly affecting its sorting or its ability to be recruited to other protein complexes that might regulate intracellular signaling pathways.
The dual role of PCDH19 related to its two functional domains (extracellular and intracellular domain), which are in contact with different compartments and partners, endows PCDH19 the capability to play several functions in different pathways. All the pathogenic mutations identified in PCDH19 gene could impair one of these cellular signaling pathways or functions.
CONCLUSIONS AND FUTURE PERSPECTIVES
EIEE9 pathology is characterized by a peculiar mode of inheritance and heterogeneity in clinical symptoms. The pathological mechanism is not known yet and we believe that this is likely due to the multiple roles of PCDH19.
Hence, it is fundamental to precisely know which are the biological processes in which PCDH19 is involved in a physiological context in order to find out defined targets and develop specific therapies for EIEE9 patients.
The investigation of PCDH19 synaptic function in animal models will be necessary to understand whether and how its mosaic expression affects the correct formation and functioning of brain circuits. Equally important will be the generation and characterization of disease-relevant cellular models for EIEE9, exploiting patient-derived iPSCs. Finally, the development of new strategies based on CRISPR/Cas9 technology able to rescue the "cellular interference" phenotype will be instrumental to the definition of the specific functions of PCDH19 subdomains and possibly to the rescue of the cellular defects.
